Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$113.88 /

+0.38 (+0.33%)

16:05
01/19/21
01/19
16:05
01/19/21
16:05

Fate Therapeutics price target raised to $135 from $70 at Oppenheimer

Oppenheimer analyst Matthew Biegler raised the firm's price target on Fate Therapeutics to $135 from $70 and reiterates an Outperform rating on the shares. Following last December's clinical update, investors "have awakened to the potential of Fate's iPSC platform," Biegler tells investors in a research note. To justify the company's valuation, it is necessary to consider the opportunities of iPSC-derived therapies in earlier treatment settings and solid tumors, areas where current cell therapies may be impractical, says the analyst. He believes the "scalability, consistency, and engineering-friendly nature" of iPSCs could allow them to succeed "where others have fallen short." As such, Biegler updated his model to ascribe value to FT596 in second-line follicular lymphoma and FT536 in non small cell lung cancer.

  • 09

    Jun

  • 06

    Jan

FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

01/15/21 Barclays
Fate Therapeutics price target raised to $130 from $110 at Barclays
12/21/20 Stifel
Fate Therapeutics price target raised to $118 from $79 at Stifel
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
12/17/20 Barclays
Fate Therapeutics price target raised to $110 from $80 at Barclays

TODAY'S FREE FLY STORIES

Initiation
I-MAB initiated with an Overweight at Piper Sandler » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
IMAB

I-MAB

$57.93 /

+0.58 (+1.01%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

12/07/20 H.C. Wainwright
I-MAB initiated with a Buy at H.C. Wainwright
09/08/20 Cantor Fitzgerald
I-MAB price target raised to $55 from $50 at Cantor Fitzgerald
07/27/20 Cantor Fitzgerald
I-MAB initiated with an Overweight at Cantor Fitzgerald
  • 09
    Feb
  • 13
    Jan
IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

General news
John Williams Speech to be released at 15:00  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
Conference/Events
Morgan Stanley financial analysts to hold analyst/industry conference call » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

Global Head of Banks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Pending Home Sales Index Month over Month to be reported at 10:00 » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

January Pending Home…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

General news
Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 08:30  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
General news
Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 12:00  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
General news
Week of 2/24 Fed Balance Sheet to be released at 16:30  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
Conference/Events
UBS technology analysts to hold an analyst/industry conference call » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
NVDA

Nvidia

$580.21 /

+14.61 (+2.58%)

Technology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

02/22/21 BMO Capital
Nvidia price target raised to $680 from $650 at BMO Capital
02/22/21 Deutsche Bank
Nvidia price target raised to $550 from $515 at Deutsche Bank
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

Conference/Events
Jefferies investment analysts to hold analyst/industry conference call » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

Investment Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Martin Marietta to hold virtual investor day » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
MLM

Martin Marietta

$348.05 /

+12.12 (+3.61%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLM Martin Marietta
$348.05 /

+12.12 (+3.61%)

MLM Martin Marietta
$348.05 /

+12.12 (+3.61%)

02/10/21 DA Davidson
Martin Marietta price target raised to $335 from $230 at DA Davidson
02/03/21 Raymond James
Martin Marietta initiated with a Market Perform at Raymond James
01/27/21 Exane BNP Paribas
Martin Marietta downgraded to Neutral from Outperform at Exane BNP Paribas
01/22/21 JPMorgan
Martin Marietta price target raised to $335 from $310 at JPMorgan
MLM Martin Marietta
$348.05 /

+12.12 (+3.61%)

MLM Martin Marietta
$348.05 /

+12.12 (+3.61%)

MLM Martin Marietta
$348.05 /

+12.12 (+3.61%)

General news
Jobless Claims Initial to be reported at 08:30 » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

Week of 2/20 Jobless…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 2/19 EIA Natural Gas Report to be released at 10:30  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
Conference/Events
McKesson participates in a conference call with Morgan Stanley » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
MCK

McKesson

$181.34 /

+0.595 (+0.33%)

Healthcare Services,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCK McKesson
$181.34 /

+0.595 (+0.33%)

MCK McKesson
$181.34 /

+0.595 (+0.33%)

02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
02/03/21 Mizuho
McKesson price target raised to $190 from $178 at Mizuho
02/01/21 Cowen
McKesson price target raised to $210 from $186 at Cowen
MCK McKesson
$181.34 /

+0.595 (+0.33%)

MCK McKesson
$181.34 /

+0.595 (+0.33%)

MCK McKesson
$181.34 /

+0.595 (+0.33%)

MCK McKesson
$181.34 /

+0.595 (+0.33%)

General news
Durable Goods Orders to be reported at 08:30 » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

January Durable Goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
SVB Leerink to hold a virtual conference » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
ACRS

Aclaris Therapeutics

$20.72 /

-0.3 (-1.43%)

, BBIO

BridgeBio

$67.57 /

+1.67 (+2.53%)

, HLIO

Helios Technologies

$66.75 /

+1.46 (+2.24%)

, MTCR

Metracrine

$8.81 /

+0.21 (+2.44%)

, SIEN

Sientra

$8.05 /

-0.04 (-0.49%)

, TRVI

Trevi Therapeutics

$2.88 /

+0.05 (+1.77%)

, VCYT

Veracyte

$62.37 /

+0.88 (+1.43%)

, VINC

Vincera Pharma

$20.21 /

+1.21 (+6.37%)

, CTSO

CytoSorbents

$10.13 /

+0.04 (+0.40%)

, CTLT

Catalent

$115.09 /

+2.215 (+1.96%)

, IMRA

Imara

$12.94 /

+0.62 (+5.03%)

, ITOS

iTeos Therapeutics

$41.00 /

+1.05 (+2.63%)

, LLY

Eli Lilly

$204.64 /

+2.21 (+1.09%)

, AUPH

Aurinia Pharmaceuticals

$14.57 /

+0.21 (+1.46%)

, AVXL

Anavex

$12.38 /

+0.29 (+2.40%)

, DRIO

DarioHealth

$28.90 /

+0.15 (+0.52%)

, ENTA

Enanta

$51.76 /

+0.38 (+0.74%)

, EQ

Equillium

$7.87 /

-0.4 (-4.84%)

, EXEL

Exelixis

$22.69 /

+0.47 (+2.12%)

, SDGR

Schrodinger

$110.89 /

+2.09 (+1.92%)

10th Annual Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$20.72 /

-0.3 (-1.43%)

BBIO BridgeBio
$67.57 /

+1.67 (+2.53%)

HLIO Helios Technologies
$66.75 /

+1.46 (+2.24%)

MTCR Metracrine
$8.81 /

+0.21 (+2.44%)

SIEN Sientra
$8.05 /

-0.04 (-0.49%)

TRVI Trevi Therapeutics
$2.88 /

+0.05 (+1.77%)

VCYT Veracyte
$62.37 /

+0.88 (+1.43%)

VINC Vincera Pharma
$20.21 /

+1.21 (+6.37%)

CTSO CytoSorbents
$10.13 /

+0.04 (+0.40%)

CTLT Catalent
$115.09 /

+2.215 (+1.96%)

IMRA Imara
$12.94 /

+0.62 (+5.03%)

ITOS iTeos Therapeutics
$41.00 /

+1.05 (+2.63%)

LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

AVXL Anavex
$12.38 /

+0.29 (+2.40%)

DRIO DarioHealth
$28.90 /

+0.15 (+0.52%)

ENTA Enanta
$51.76 /

+0.38 (+0.74%)

EQ Equillium
$7.87 /

-0.4 (-4.84%)

EXEL Exelixis
$22.69 /

+0.47 (+2.12%)

SDGR Schrodinger
$110.89 /

+2.09 (+1.92%)

ACRS Aclaris Therapeutics
$20.72 /

-0.3 (-1.43%)

02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
BBIO BridgeBio
$67.57 /

+1.67 (+2.53%)

02/22/21 JPMorgan
BridgeBio reinstated with an Overweight at JPMorgan
02/09/21
Fly Intel: Top five analyst initiations
02/09/21 Goldman Sachs
BridgeBio reinstated with a Buy at Goldman Sachs
01/11/21 H.C. Wainwright
BridgeBio price target raised to $87 from $64 at H.C. Wainwright
HLIO Helios Technologies
$66.75 /

+1.46 (+2.24%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 SunTrust
Helios Technologies price target lowered to $36 from $45 at SunTrust
MTCR Metracrine
$8.81 /

+0.21 (+2.44%)

10/12/20 Canaccord
Metracrine initiated with a Buy at Canaccord
10/12/20 Jefferies
Metracrine initiated with a Buy at Jefferies
10/12/20 RBC Capital
Metracrine initiated with an Outperform at RBC Capital
SIEN Sientra
$8.05 /

-0.04 (-0.49%)

02/05/21 Canaccord
Sientra price target raised to $8 from $6 at Canaccord
10/08/20 Stifel
Stifel sees upside potential for Sientra after survey of aesthetics doctors
06/11/20 Maxim
Sientra price target raised to $8 from $5 at Maxim
03/12/20 Craig-Hallum
Sientra price target lowered to $9 from $14 at Craig-Hallum
TRVI Trevi Therapeutics
$2.88 /

+0.05 (+1.77%)

07/13/20 Stifel
Trevi Therapeutics price target lowered to $10 from $14 at Stifel
VCYT Veracyte
$62.37 /

+0.88 (+1.43%)

02/18/21 Needham
Veracyte assumed with a Buy at Needham
02/08/21 SVB Leerink
Veracyte price target raised to $83 from $40 at SVB Leerink
01/27/21 Truist
Veracyte initiated with a Buy at Truist
12/17/20 Lake Street
Veracyte price target raised to $60 from $40 at Lake Street
VINC Vincera Pharma
$20.21 /

+1.21 (+6.37%)

01/06/21 Chardan
Vincera Pharma initiated with a Buy at Chardan
CTSO CytoSorbents
$10.13 /

+0.04 (+0.40%)

01/04/21 B. Riley Securities
CytoSorbents price target raised to $17 from $16 at B. Riley Securities
09/01/20 SVB Leerink
CytoSorbents initiated with an Outperform at SVB Leerink
08/25/20 B. Riley FBR
CytoSorbents 29% pullback from highs a buying opportunity, says B. Riley FBR
06/02/20 B. Riley FBR
CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR
CTLT Catalent
$115.09 /

+2.215 (+1.96%)

02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
01/08/21 JPMorgan
Catalent price target raised to $130 from $110 at JPMorgan
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
IMRA Imara
$12.94 /

+0.62 (+5.03%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
ITOS iTeos Therapeutics
$41.00 /

+1.05 (+2.63%)

10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/01/20 Piper Sandler
iTeos Therapeutics heading for 'catalyst rich stretch', says Piper Sandler
08/18/20 SVB Leerink
SVB Leerink bullish on iTeos Therapeutics, initiates with an Outperform
LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
02/12/21 Cowen
Eli Lilly price target raised to $235 from $195 at Cowen
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

01/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $28 from $20 at RBC Capital
01/26/21 Cantor Fitzgerald
Aurinia Pharmaceuticals price target raised to $34 from $27 at Cantor Fitzgerald
01/25/21 Oppenheimer
Aurinia Pharmaceuticals price target raised to $28 from $20 at Oppenheimer
01/25/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $35 from $30 at H.C. Wainwright
AVXL Anavex
$12.38 /

+0.29 (+2.40%)

02/24/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
02/23/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
12/29/20 Cantor Fitzgerald
Anavex cash position to fund operations into 2022, says Cantor Fitzgerald
12/16/20 H.C. Wainwright
Anavex price target raised to $17 from $14 at H.C. Wainwright
DRIO DarioHealth
$28.90 /

+0.15 (+0.52%)

02/01/21 Alliance Global Partners
DarioHealth downgraded to Neutral from Buy at Alliance Global Partners
08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
ENTA Enanta
$51.76 /

+0.38 (+0.74%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
EQ Equillium
$7.87 /

-0.4 (-4.84%)

11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
EXEL Exelixis
$22.69 /

+0.47 (+2.12%)

02/15/21 Piper Sandler
Exelixis price target raised to $36 from $33 at Piper Sandler
01/25/21 Piper Sandler
Piper says Exelixis could have 'blockbuster opportunity' with XL102
01/22/21 Piper Sandler
Exelixis combo approval came a month ahead of PDUFA, says Piper Sandler
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
SDGR Schrodinger
$110.89 /

+2.09 (+1.92%)

01/25/21 BMO Capital
Schrodinger price target raised to $117 from $97 at BMO Capital
11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
ACRS Aclaris Therapeutics
$20.72 /

-0.3 (-1.43%)

BBIO BridgeBio
$67.57 /

+1.67 (+2.53%)

HLIO Helios Technologies
$66.75 /

+1.46 (+2.24%)

MTCR Metracrine
$8.81 /

+0.21 (+2.44%)

SIEN Sientra
$8.05 /

-0.04 (-0.49%)

VCYT Veracyte
$62.37 /

+0.88 (+1.43%)

CTSO CytoSorbents
$10.13 /

+0.04 (+0.40%)

CTLT Catalent
$115.09 /

+2.215 (+1.96%)

IMRA Imara
$12.94 /

+0.62 (+5.03%)

ITOS iTeos Therapeutics
$41.00 /

+1.05 (+2.63%)

LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

AVXL Anavex
$12.38 /

+0.29 (+2.40%)

DRIO DarioHealth
$28.90 /

+0.15 (+0.52%)

ENTA Enanta
$51.76 /

+0.38 (+0.74%)

EQ Equillium
$7.87 /

-0.4 (-4.84%)

EXEL Exelixis
$22.69 /

+0.47 (+2.12%)

SDGR Schrodinger
$110.89 /

+2.09 (+1.92%)

  • 12
    Feb
  • 09
    Feb
  • 05
    Feb
  • 20
    Jan
  • 23
    Nov
  • 16
    Sep
  • 14
    Aug
  • 13
    Aug
  • 05
    Aug
  • 24
    Jul
  • 23
    Jul
  • 22
    Jul
  • 11
    Jun
  • 29
    May
  • 12
    Mar
BBIO BridgeBio
$67.57 /

+1.67 (+2.53%)

LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

ACRS Aclaris Therapeutics
$20.72 /

-0.3 (-1.43%)

BBIO BridgeBio
$67.57 /

+1.67 (+2.53%)

MTCR Metracrine
$8.81 /

+0.21 (+2.44%)

SIEN Sientra
$8.05 /

-0.04 (-0.49%)

VCYT Veracyte
$62.37 /

+0.88 (+1.43%)

VINC Vincera Pharma
$20.21 /

+1.21 (+6.37%)

CTLT Catalent
$115.09 /

+2.215 (+1.96%)

IMRA Imara
$12.94 /

+0.62 (+5.03%)

LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

AVXL Anavex
$12.38 /

+0.29 (+2.40%)

ENTA Enanta
$51.76 /

+0.38 (+0.74%)

EQ Equillium
$7.87 /

-0.4 (-4.84%)

EXEL Exelixis
$22.69 /

+0.47 (+2.12%)

SDGR Schrodinger
$110.89 /

+2.09 (+1.92%)

LLY Eli Lilly
$204.64 /

+2.21 (+1.09%)

AUPH Aurinia Pharmaceuticals
$14.57 /

+0.21 (+1.46%)

SDGR Schrodinger
$110.89 /

+2.09 (+1.92%)

Conference/Events
1-800-Flowers.com participates in a conference call with Benchmark » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
FLWS

1-800-Flowers.com

$30.98 /

-0.54 (-1.71%)

Internet, Media &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$30.98 /

-0.54 (-1.71%)

FLWS 1-800-Flowers.com
$30.98 /

-0.54 (-1.71%)

10/29/20 Benchmark
1-800-Flowers.com selloff brings 'excellent' opportunity, says Benchmark
08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
FLWS 1-800-Flowers.com
$30.98 /

-0.54 (-1.71%)

FLWS 1-800-Flowers.com
$30.98 /

-0.54 (-1.71%)

Conference/Events
Accuray participates in a conference call with Cowen » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
ARAY

Accuray

$5.26 /

-0.015 (-0.28%)

Medical Devices Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAY Accuray
$5.26 /

-0.015 (-0.28%)

ARAY Accuray
$5.26 /

-0.015 (-0.28%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
09/28/20 Lake Street
CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street
09/18/20 Cowen
New CMS model should provide tailwind for Accuray, says Cowen
ARAY Accuray
$5.26 /

-0.015 (-0.28%)

ARAY Accuray
$5.26 /

-0.015 (-0.28%)

General news
Week of 2/20 Jobless Claims to be released at 08:30  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
General news
6-Month Bill Announcement to be released at 11:00  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
General news
8-Week Bill Auction to be released at 11:30  04:55
02/25/21
02/25
04:55
02/25/21
04:55
 
Conference/Events
Akamai to host virtual investor day » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
AKAM

Akamai

$97.57 /

-0.16 (-0.16%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKAM Akamai
$97.57 /

-0.16 (-0.16%)

AKAM Akamai
$97.57 /

-0.16 (-0.16%)

02/10/21
Fly Intel: Top five analyst downgrades
02/10/21 Craig-Hallum
Akamai downgraded to Hold at Craig-Hallum
02/10/21 Credit Suisse
Akamai price target raised to $115 from $105 at Credit Suisse
02/10/21 Craig-Hallum
Akamai downgraded to Hold from Buy at Craig-Hallum
AKAM Akamai
$97.57 /

-0.16 (-0.16%)

AKAM Akamai
$97.57 /

-0.16 (-0.16%)

AKAM Akamai
$97.57 /

-0.16 (-0.16%)

Conference/Events
Crane to hold virtual investor day » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
CR

Crane

$87.57 /

+1.57 (+1.83%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CR Crane
$87.57 /

+1.57 (+1.83%)

01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
01/07/21 DA Davidson
Crane cut to Neutral at DA Davidson on valuation
01/07/21 DA Davidson
Crane downgraded to Neutral from Buy at DA Davidson
10/07/20 DA Davidson
DA Davidson positive on Crane's Engineered Materials, PMT segments
CR Crane
$87.57 /

+1.57 (+1.83%)

CR Crane
$87.57 /

+1.57 (+1.83%)

Conference/Events
Hasbro to host virtual investor day » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
HAS

Hasbro

$91.00 /

-0.4 (-0.44%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAS Hasbro
$91.00 /

-0.4 (-0.44%)

HAS Hasbro
$91.00 /

-0.4 (-0.44%)

02/09/21 DA Davidson
Hasbro price target raised to $115 from $105 at DA Davidson
02/09/21 BMO Capital
Hasbro price target lowered to $85 from $90 at BMO Capital
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/26/21 JPMorgan
JPMorgan ups Hasbro target but sees guidance missing estimates
HAS Hasbro
$91.00 /

-0.4 (-0.44%)

HAS Hasbro
$91.00 /

-0.4 (-0.44%)

Conference/Events
Royal Dutch Shell to hold a conference call » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
RDS.B

Royal Dutch Shell

$40.66 /

+1.64 (+4.20%)

, RDS.A

Royal Dutch Shell

$42.38 /

+1.31 (+3.19%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDS.B Royal Dutch Shell
$40.66 /

+1.64 (+4.20%)

RDS.A Royal Dutch Shell
$42.38 /

+1.31 (+3.19%)

RDS.B Royal Dutch Shell
$40.66 /

+1.64 (+4.20%)

02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
01/27/21 JPMorgan
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at JPMorgan
01/15/21 JPMorgan
Royal Dutch Shell price target raised to 1,800 GBp from 1,700 GBp at JPMorgan
12/23/20 MKM Partners
Royal Dutch Shell initiated with a Buy at MKM Partners
RDS.A Royal Dutch Shell
$42.38 /

+1.31 (+3.19%)

02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
02/08/21 Cowen
Royal Dutch Shell price target lowered to $45 from $50 at Cowen
01/27/21 JPMorgan
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at JPMorgan
01/21/21 Jefferies
Royal Dutch Shell initiated with a Buy at Jefferies
RDS.B Royal Dutch Shell
$40.66 /

+1.64 (+4.20%)

RDS.A Royal Dutch Shell
$42.38 /

+1.31 (+3.19%)

RDS.B Royal Dutch Shell
$40.66 /

+1.64 (+4.20%)

RDS.A Royal Dutch Shell
$42.38 /

+1.31 (+3.19%)

RDS.B Royal Dutch Shell
$40.66 /

+1.64 (+4.20%)

RDS.A Royal Dutch Shell
$42.38 /

+1.31 (+3.19%)

General news
GDP Quarter over Quarter to be reported at 08:30 » 04:55
02/25/21
02/25
04:55
02/25/21
04:55

GDP Quarter over Quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.